A Prospective Study of the Clinical and Demographic Profile of Type 2 Diabetes Mellitus Patients Receiving Antidiabetic Drug Combinations.

Conclusion A combination of metformin with sulfonylurea was the preferred first-line treatment; insulin was added when the HbA1c was >9. Patients who received dose escalation had a longer duration of the disease and higher FBG and HbA1c.
PMID: 31250763 [PubMed - as supplied by publisher]

Source: Current Diabetes Reviews - June 18, 2019 Category: Endocrinology Authors: Gadgade A, Shenoy A, Kamath A, Kamath P, Adhikari P, Rs N, Hadigal S, N S, Shenoy N, Chowta MN Tags: Curr Diabetes Rev Source Type: research